Identification of Activated T Lymphocytes and Eosinophils in Bronchial Biopsies in Stable Atopic Asthma
- 30 November 1990
- journal article
- research article
- Published by American Thoracic Society in American Review of Respiratory Disease
- Vol. 142 (6_pt_1) , 1407-1413
- https://doi.org/10.1164/ajrccm/142.6_pt_1.1407
Abstract
We have used immunohistochemistry and monoclonal antibodies to analyze the phenotypic composition and activation status of the cellular infiltrate of bronchial biopsies obtained by fiber optic bronchoscopy of 11 atopic asthmatic subjects (FEV1% predicted range 78 to 114), atopic nonasthmatic control subjects, and 10 normal healthy subjects. Examination of mucosal biopsies obtained from both central (level I) and subsegmental (level II) bronchi showed that the highest number of CD45-, DC3-, DC4-, and CD8-positive cells were found in the group with asthma. There was a significant increase in the number of interleukin-2 receptor (CD25)-positive cells (a marker of lymphocyte activation) at airway level I in the asthmatic group compared with both nonasthmatic atopic (p < 0.05) and normal control subjects (p < 0.01). Eosinophil numbers were significantly increased in asthma at both airway levels and at airway level II in the nonasthmatic atopic group when compared with normal healthy control subjects (p < 0.05). EG2-positive cells (an index of secretion of eosinophil cationic protein following activation) were found at both airway levels in the asthmatic group and at level I in the nonasthmatic atopic control group (p < 0.05). When asthmatic subjects were compared with normal healthy subjects, there was a reduction in the number of neutrophil elastase-positive cells in the asthmatic subjects which, as a percentage of leukocytes, was significant (p = 0.05). When normoresponsive subjects were compared with hyperresponsive subjects (PC20 < 8 mg/ml methacholine), the hyperresponsive subjects had a significantly higher percentage of CD25-positive cells at airway level I (p < 0.01) and of EG2-positive cells at levels I and II (p < 0.01). These results support the view that the recruitment and "activation" of lymphocytes and eosinophils are important in the pathogenesis of bronchial asthma.This publication has 23 references indexed in Scilit:
- Enhancement by monokines of leukotriene generation by human eosinophils and neutrophils stimulated with calcium ionophore A23187.The Journal of Immunology, 1986
- Murine eosinophil differentiation factor. An eosinophil-specific colony-stimulating factor with activity for human cells.The Journal of Experimental Medicine, 1986
- Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae.Proceedings of the National Academy of Sciences, 1986
- Identification of a lymphokine that stimulates eosinophil differentiation in vitro. Its relationship to interleukin 3, and functional properties of eosinophils produced in cultures.The Journal of Experimental Medicine, 1985
- Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity.The Journal of Immunology, 1983
- DETERMINANTS OF ALLERGEN-INDUCED ASTHMA - DOSE OF ALLERGEN, CIRCULATING IGE ANTIBODY CONCENTRATION, AND BRONCHIAL RESPONSIVENESS TO INHALED HISTAMINEPublished by Elsevier ,1979
- Alkaline phosphatase and peroxidase for double immunoenzymatic labelling of cellular constituents.Journal of Clinical Pathology, 1978
- Some histological changes in chronic bronchitis and asthmaThorax, 1968
- THE PATHOLOGY OF ASTHMA, WITH SPECIAL REFERENCE TO CHANGES IN THE BRONCHIAL MUCOSAJournal of Clinical Pathology, 1960
- A Clinical and Pathological Study of Fatal Cases of Status AsthmaticusThorax, 1953